PARVOVIRUS INFECTION IN CHILDREN WITH AIDS - HIGH PREVALENCE OF B19-SPECIFIC IMMUNOGLOBULIN-M AND IMMUNOGLOBULIN-G ANTIBODIES

被引:14
作者
NIGRO, G
LUZI, G
FRIDELL, E
FERRARA, M
PISANO, P
GATTINARA, GC
MEZZAROMA, I
SODERLUND, M
RASNOVEANU, D
AIUTI, F
机构
[1] OSPED BAMBINO GESU,ROME,ITALY
[2] VICTOR BABES HOSP,BUCHAREST,ROMANIA
[3] LA SAPIENZA,DEPT ALLERGY & CLIN IMMUNOL,I-00161 ROME,ITALY
[4] NATL BACTERIOL LAB,DEPT VIROL,S-10521 STOCKHOLM,SWEDEN
[5] KAROLINSKA INST,S-10401 STOCKHOLM 60,SWEDEN
[6] UNIV HELSINKI,DEPT VIROL,SF-00100 HELSINKI 10,FINLAND
关键词
PEDIATRIC AIDS; PARVOVIRUS B19; ANEMIA;
D O I
10.1097/00002030-199207000-00010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: investigation of the prevalence and pathogenic role of parvovirus B19 infection in Italian and Rumanian children with AIDS, compared with age-matched HIV-negative children (controls) with various recurrent infections of unknown aetiology. Design: Detection of B19-specific immunoglobulin (Ig) M and IgG antibodies as the most indicative markers of past or current B19 infection. Methods: B19 antibodies were detected by two enzyme immunoassays using synthetic peptide or recombinant protein, which corresponded to different B19 epitopes, as coating antigens. Results: B19 IgM and IgG were seen in 10 out of 20 (50 %) Italian and in 20 out of 51 (39.2%) Rumanian children with AIDS, in contrast to none out of 17 Italian and one out of 22 Rumanian controls (P < 0.001). In addition, two Italian controls (11.8%), two Rumanian children with AIDS (3.9%), and two Rumanian controls (9.1%) had B19 IgM alone. Specific IgG alone was detected in eight (40%) Italian and 14 (27.5%) Rumanian children with AIDS, and in seven (41.2%) Italian and four (10.2%) Rumanian controls. Conclusions: While it is possible to attribute some B19 infections in Rumanian children to blood transfusion, the source was unknown for Italian children. However, in three of the Italian children who had B19 IgM and IgG persistently for 15-22 months, and in a 2-month-old italian infant with B19 IgM and IgG, HIV might have activated a congenital or perinatally-acquired B19 infection.
引用
收藏
页码:679 / 684
页数:6
相关论文
共 36 条
[1]   HUMAN PARVOVIRUSES [J].
ANDERSON, LJ .
JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (04) :603-608
[2]   EXPERIMENTAL PARVOVIRAL INFECTION IN HUMANS [J].
ANDERSON, MJ ;
HIGGINS, PG ;
DAVIS, LR ;
WILLMAN, JS ;
JONES, SE ;
KIDD, IM ;
PATTISON, JR ;
TYRRELL, DAJ .
JOURNAL OF INFECTIOUS DISEASES, 1985, 152 (02) :257-265
[3]   AN OUTBREAK OF ERYTHEMA INFECTIOSUM ASSOCIATED WITH HUMAN PARVOVIRUS INFECTION [J].
ANDERSON, MJ ;
LEWIS, E ;
KIDD, IM ;
HALL, SM ;
COHEN, BJ .
JOURNAL OF HYGIENE, 1984, 93 (01) :85-93
[4]   HUMAN PARVOVIRUS-B19 INFECTION AMONG HOSPITAL STAFF MEMBERS AFTER CONTACT WITH INFECTED PATIENTS [J].
BELL, LM ;
NAIDES, SJ ;
STOFFMAN, P ;
HODINKA, RL ;
PLOTKIN, SA .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (08) :485-491
[5]  
BOWMAN CA, 1990, AIDS, V4, P1038, DOI 10.1097/00002030-199010000-00021
[6]   OCCUPATIONAL RISK-FACTORS FOR INFECTION WITH PARVOVIRUS B19 AMONG PREGNANT-WOMEN [J].
CARTTER, ML ;
FARLEY, TA ;
ROSENGREN, S ;
QUINN, DL ;
GILLESPIE, SM ;
GARY, GW ;
HADLER, JL .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (02) :282-285
[7]   THE ROLE OF PARVOVIRUS-B19 IN APLASTIC CRISIS AND ERYTHEMA INFECTIOSUM (5TH DISEASE) [J].
CHORBA, T ;
COCCIA, P ;
HOLMAN, RC ;
TATTERSALL, P ;
ANDERSON, LJ ;
SUDMAN, J ;
YOUNG, NS ;
KURCZYNSKI, E ;
SAARINEN, UM ;
MOIR, R ;
LAWRENCE, DN ;
JASON, JM ;
EVATT, B .
JOURNAL OF INFECTIOUS DISEASES, 1986, 154 (03) :383-393
[8]   CASE-REPORT - ELECTRON-MICROSCOPIC DETECTION OF HUMAN PARVOVIRUS (B19) IN A PATIENT WITH HIV-INFECTION [J].
CHRYSTIE, IL ;
ALMEIDA, JD ;
WELCH, J .
JOURNAL OF MEDICAL VIROLOGY, 1990, 30 (04) :249-252
[9]   THE PREVALENCE OF ANTIBODY TO HUMAN PARVOVIRUS-B19 IN ENGLAND AND WALES [J].
COHEN, BJ ;
BUCKLEY, MM .
JOURNAL OF MEDICAL MICROBIOLOGY, 1988, 25 (02) :151-153
[10]   HUMAN PARVOVIRUS INFECTION IN HEMOPHILIACS 1ST INFUSED WITH TREATED CLOTTING FACTOR CONCENTRATES [J].
CORSI, OB ;
AZZI, A ;
MORFINI, M ;
FANCI, R ;
ROSSIFERRINI, P .
JOURNAL OF MEDICAL VIROLOGY, 1988, 25 (02) :165-170